title: '"Governing Biotechnology: From Avian Flu to Genetically-Modified Babies With
  Catherine Rhodes"'
original_url: '"https://zencastr.com/z/c9Dp6j8c"'
date_published: '2018-11-30'
host:
  name: Arielle Kahn
  affiliation: Future of Life Institute
guests:
- name: Catherine Rhodes
  affiliation: Center for the Study of Existential Risk
  title: Senior Research Associate and Deputy Director
  bio: Catherine Rhodes is a senior research associate and deputy director focused
    on understanding the intersection of risks stemming from technologies and governance.
  expertise_areas:
  - International governance of biotechnology
  - Biosecurity
  - Risk management
synopsis: In this episode, Arielle Kahn interviews Catherine Rhodes to explore the
  risks and governance associated with biotechnology, including the ethical implications
  of gene editing and emerging technologies. They discuss the balance between innovation
  and safety in scientific research.
key_topics:
- Biotechnology risks and biosecurity
- Genetically edited babies
- Gain of function research
- Communication between scientists and policymakers
- Ethical implications of biological research
tags:
- Biotechnology
- Ethics
- Policy
- Biosecurity
key_points:
- Understanding biological risk and the importance of protective measures.
- The ethical challenges posed by gain of function experiments.
- Need for improved communication and education between scientific and policy communities.
- The responsibility of scientists, policymakers, and the public in ensuring ethical
  research.
segments:
- title: Introduction to Biotechnology Risks
  summary: Arielle Kahn introduces the topic of biotechnology, its associated risks,
    and welcomes guest Catherine Rhodes.
  key_quotes:
  - quote: '"It''s about the protection of human, animal, and plant life and health
      in particular."'
    speaker: Catherine Rhodes
    context: Defining biological risk and security.
- title: '"Genetically Edited Babies: Ethical Shock"'
  summary: '"Discussion on the recent claims of the world''s first genetically edited
    babies and its implications for ethics and regulation."'
  key_quotes:
  - quote: This case... provides a nice jumping off point to consider regulations,
      ethics, and risks.
    speaker: Arielle Kahn
    context: Opening remarks about the recent gene editing news.
- title: Defining Biological Risks and Security
  summary: '"Catherine Rhodes defines the terms ''biological risk'' and ''biological
    security.''"'
  key_quotes:
  - quote: The risks are the risks to those objects and security is securing and protecting
      those.
    speaker: Catherine Rhodes
    context: Clarifying definitions of biological risk and security.
- title: Ethical Implications of Gain of Function Research
  summary: Exploration of gain of function research practices and the ethical concerns
    involved.
  key_quotes:
  - quote: Gain of function was actually quite a controversial term to have selected.
    speaker: Catherine Rhodes
    context: Discussing the terminology in scientific communities.
- title: Communication Challenges in Science and Policy
  summary: Discussion about the terminological challenges in scientific and policy
    communication.
  key_quotes:
  - quote: Our choice of terminology affect how we perceive the ethics of some of
      these projects.
    speaker: Catherine Rhodes
    context: Reflecting on the impact of language in research discussions.
websites_referenced:
- url: '"https://www.who.int/"'
  name: World Health Organization
  context: Organization involved in promoting safety in life sciences.
  access_date: '2023-10-01'
tools_mentioned:
- name: ''
  url: ''
  description: ''
  context: ''
research_papers:
- title: Biosecurity and the Need for Enhanced Awareness in Biological Research
  authors:
  - Catherine Rhodes
  year: 2018
  url: ''
  key_findings: Highlighted the importance of governance and public perception in
    biotech risks.
  context: Supports discussions in the podcast regarding biosafety.
books_referenced:
- title: ''
  authors: []
  year: null
  isbn: ''
  context: ''
organizations:
  academic_institutions:
  - name: Center for the Study of Existential Risk
    location: Cambridge, UK
    context: Studies risks related to emerging technologies.
  companies:
  - name: ''
    industry: ''
    context: ''
  non_profits:
  - name: Future of Life Institute
    focus_area: Mitigating existential risks from advanced technologies
    context: '"Arielle Kahn''s affiliation for the podcast."'
  government_agencies:
  - name: ''
    country: ''
    context: ''
notable_people:
  academics:
  - name: Catherine Rhodes
    institution: Center for the Study of Existential Risk
    field: Biosecurity and risk management
    context: Guest expert on biotechnology issues.
  industry_leaders:
  - name: ''
    company: ''
    role: ''
    context: ''
  policy_makers:
  - name: ''
    role: ''
    organization: ''
    context: ''
projects_mentioned:
- name: ''
  organization: ''
  description: ''
  status: ''
  url: ''
  context: ''
events:
  historical:
  - name: Asilomar Conference on Recombinant DNA
    date: 1975
    significance: Biologists paused research to address ethical concerns.
    context: Referenced as a historical example of ethical awareness.
  upcoming:
  - name: ''
    date: null
    location: ''
    description: ''
    url: ''
keywords:
- biotechnology
- ethics
- governance
- biosecurity
categories:
- Science
- Ethics
- Policy
intended_audience: Policymakers, researchers, and the general public interested in
  biotechnology.
expertise_level: Intermediate
recommended_reading:
- title: Biosecurity and Ethical Governance in Biotechnology
  url: ''
  type: Research Paper
  relevance: Contextualizes the themes discussed in the podcast.
action_items:
- Enhance communication between scientists and policymakers.
- Raise awareness of ethical implications in biotechnological research.
controversial_topics:
- topic: Genetically Edited Babies
  different_viewpoints:
  - perspective: Support for innovation
    proponents: Some scientists and bioethicists
    key_arguments: Potential benefits for medical advancement.
  - perspective: Opposition due to ethical risks
    proponents: Ethicists and many in the scientific community
    key_arguments: Concerns over safety and unknown long-term effects.
